"When the researchers combined PAM4 with another test, CA19-9, which is already approved to monitor pancreatic cancer during treatment, the combination showed even stronger results and correctly identified 85 percent of patients with pancreatic ductal adenomcarcinoma (PDAC), by far the most common form of pancreatic cancer. More study of PAM4 may even point to possible targets for therapy, the authors stated.
"For providers of care for patients with pancreatic cancer, hampered by their inability to readily detect these cancers in some cases, especially in earlier stages, this shows tremendous promise that blood-based assay can add to our ability to diagnose pancreatic cancer at an earlier stage, thereby impacting patients lives," said Dr. Morton S. Kahlenberg, a gastrointestinal cancers expert with the American Society of Clinical Oncology and moderator of a Tuesday press briefing on the findings."
This is promising news for those who may not be aware they're potentially in Pancreatic Cancer's cross-hairs. I've always liked the old saying: prevention is better than a cure!
But, of course, I'd still like to see a cure found. I feel with all the info and technology available today - and in the near future, it can't be too far away.